Livzon Pharmaceutical Group (HKSE:01513) Common Stock : HK$1,007 Mil (As of Mar. 2024)

View and export this data going back to 2014. Start your Free Trial

What is Livzon Pharmaceutical Group Common Stock?

Livzon Pharmaceutical Group's quarterly common stock increased from Sep. 2023 (HK$1,004 Mil) to Dec. 2023 (HK$1,011 Mil) but then declined from Dec. 2023 (HK$1,011 Mil) to Mar. 2024 (HK$1,007 Mil).

Livzon Pharmaceutical Group's annual common stock declined from Dec. 2021 (HK$1,148 Mil) to Dec. 2022 (HK$1,045 Mil) and declined from Dec. 2022 (HK$1,045 Mil) to Dec. 2023 (HK$1,011 Mil).

Livzon Pharmaceutical Group Common Stock Historical Data

The historical data trend for Livzon Pharmaceutical Group's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Livzon Pharmaceutical Group Common Stock Chart

Livzon Pharmaceutical Group Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Common Stock

Get a 7-Day Free Trial

1,040.16

1,120.04

1,148.39

1,044.75

1,010.58

Livzon Pharmaceutical Group Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Common Stock	Get a 7-Day Free Trial															1,065.59	1,023.29	1,003.57	1,010.58	1,006.62

Livzon Pharmaceutical Group Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Livzon Pharmaceutical Group (HKSE:01513) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Livzon Pharmaceutical Group Inc (HKSE:01513) » Definitions » Common Stock

Traded in Other Exchanges

LP6:Germany 000513:China

Address

38 Chuangye North Road, Headquarters Building, Jinwan District, Guangdong Province, Zhuhai, CHN, 519090

Website

https://www.livzon.com.cn

Livzon Pharmaceutical Group Inc is engaged in China's healthcare sector. As a pharmaceutical manufacturer, the company's portfolio comprises Western pharmaceutical preparations, bulk drugs, traditional Chinese medicines, as well as diagnostic reagents and equipment. Its drug address serious conditions such as gastrointestinal, cardiovascular, anti-infectious, antimicrobial, antineoplastic, hemopoietic system, and other conditions. It distributes its products within domestic markets and to overseas markets. It operates in a single reportable segment which is pharmaceutical manufacturing.

Executives

Zhu Baoguo

2201 Interest of corporation controlled by you

Livzon Pharmaceutical Group (HKSE:01513) Headlines

No Headlines